Examining current treatment options for brain metastases in metastatic HER2+ breast cancer and assessing the clinical and economic burden.
EP. 2: HER2+ mBC: Diagnosing Patients With Brain Mets
January 14th 2021Insights on diagnosing patients who have HER2+ metastatic breast cancer with brain metastases based on current NCCN Guidelines recommendations when they may present with them during the course of treatment, and the impact on quality of life.
Watch
EP. 14: Impact of Early Identification of Brain Mets
January 14th 2021A payer perspective on the impact of early identification of brain mets in HER2+ metastatic breast cancer on healthcare utilization and patient outcomes as well as recommendations to other payers managing this patient population.
Watch